Literature DB >> 22903369

Systemic amyloidosis masquerading as iron deficiency anemia.

Ramya Thota, Wilson Gonsalves, Tsewang Tashi, Shanmuga Subbiah.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22903369     DOI： 10.1007/s12664-012-0245-6

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  10 in total

Review 1.  Molecular mechanisms of amyloidosis.

Authors:  Giampaolo Merlini; Vittorio Bellotti
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

2.  Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis.

Authors:  Giovanni Palladini; Paola Russo; Mario Nuvolone; Francesca Lavatelli; Vittorio Perfetti; Laura Obici; Giampaolo Merlini
Journal:  Blood       Date:  2007-07-15       Impact factor: 22.113

3.  Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis.

Authors:  S Tada; M Iida; A Iwashita; T Matsui; T Fuchigami; T Yamamoto; T Yao; M Fujishima
Journal:  Gastrointest Endosc       Date:  1990 Jan-Feb       Impact factor: 9.427

Review 4.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

5.  Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial.

Authors:  Vaishali Sanchorawala; Daniel G Wright; Michael Rosenzweig; Kathleen T Finn; Salli Fennessey; Jerome B Zeldis; Martha Skinner; David C Seldin
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

6.  Primary systemic amyloidosis: a cause of malabsorption syndrome.

Authors:  S R Hayman; M Q Lacy; R A Kyle; M A Gertz
Journal:  Am J Med       Date:  2001-11       Impact factor: 4.965

7.  Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis.

Authors:  D M Menke; R A Kyle; C R Fleming; J T Wolfe; P J Kurtin; W A Oldenburg
Journal:  Mayo Clin Proc       Date:  1993-08       Impact factor: 7.616

Review 8.  Long-term survival (10 years or more) in 30 patients with primary amyloidosis.

Authors:  R A Kyle; M A Gertz; P R Greipp; T E Witzig; J A Lust; M Q Lacy; T M Therneau
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

9.  Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease.

Authors:  Ashutosh D Wechalekar; Helen J Lachmann; Mark Offer; Philip N Hawkins; Julian D Gillmore
Journal:  Haematologica       Date:  2008-02       Impact factor: 9.941

10.  Diagnosis of amyloidosis by abdominal fat aspiration. Analysis of four years' experience.

Authors:  M A Duston; M Skinner; T Shirahama; A S Cohen
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.